Capital Allocators
Capital Allocators

Josh Wolfe – Caution and Innovation at Lux Capital, Venture is Eating the Investment World 8 (Capital Allocators, EP.236)

Josh Wolfe is the Co-Founder and Managing Partner of Lux Capital, a $4 billion venture capital firm that invests in solutions to the most vexing puzzles of our time. Josh described his background and Lux's approach back in 2018 on the show and that conversation is replayed in the feed. This tim

Featured Speakers

Ted Seides – Allocator and Asset Management Expert HostJosh Wolfe Guest

Topics Discussed

Episode Summary

Executive Summary: Josh Wolfe argues venture capital is in a dangerous excess-of-excesses phase: too much capital, too many firms, too little diligence, and inflated valuations. Lux Capital responds by leaning into scarce, technically hard companies in science, defense, space, and infrastructure while staying skeptical of hype. He also highlights new theses around smell, crypto/NFTs, metaverse infrastructure, elemental power, and especially Africa.

Main Topics: Venture capital is awash in excess capital (Priority: 5/5): Wolfe says venture has moved beyond simple excess to an 'excess of excesses' across fundraising, valuations, deal velocity, and firm formation, with LPs and GPs both driving the boom. Lux's strategy: focus on scarce, hard-science opportunities (Priority: 5/5): Rather than compete in auctions for software-like growth, Lux looks for scientific, technically rigorous, low-competition companies where it can help create outcomes. Decision-making, skepticism, and risk reduction (Priority: 4/5): Wolfe emphasizes exploration vs. exploitation, power laws, and imaginative risk identification. He argues many investors are doing cursory diligence and writing checks out of FOMO. Updates on prior investments: Control Labs and Variant Bio (Priority: 4/5): He reflects on the sale of Control Labs to Facebook/Meta as a lesson in founder liquidity, and praises Variant Bio's mission-driven scientific platform and global partnership-building. Directional arrows of progress: smell, deception/detection, science tech, defense, metaverse, crypto (Priority: 5/5): Wolfe identifies multiple long-term theses, including scent capture, the race between deception and detection, tools for science, military-tech competition, metaverse infrastructure, and crypto primitives. Nuclear/elemental power and space manufacturing (Priority: 4/5): He argues nuclear's future depends more on public acceptance and branding than technology, and cites space manufacturing as an example of a market partly created by will and conviction. Africa as an underappreciated opportunity and geopolitical flashpoint (Priority: 5/5): Wolfe says Africa is becoming more investable due to returning diaspora talent, startup formation, and crypto/regulatory dynamics, while also becoming a major theater in U.S.-China competition and extremism.

Key Arguments: Venture is currently marked by too much capital chasing too few quality opportunities, which is inflating prices and reducing diligence. The eventual correction will likely be driven by LP indigestion as endowments and other allocators hit capacity limits and slow capital recycling. Lux can avoid auction dynamics by targeting scarce, technically complex, scientifically rigorous businesses with very few true competitors. Hard-science investing has lower competition than software, even if it entails longer validation periods and potentially smaller but still very large outcomes. Investors often underestimate founder liquidity needs; letting early employees/founders realize some wealth can materially improve retention and execution. Many breakthrough technologies require belief and narrative adoption, not just technical feasibility; timing is often a function of social acceptance. Crypto has both speculative and real infrastructure value; NFT-like digital provenance can be useful even if speculative assets are not. Africa's next wave may come from returning entrepreneurs with capital and network access, starting in fintech, logistics, and healthcare, before expanding into more sophisticated tech. Defensive and dual-use technologies across air, land, sea, space, and cyber are becoming increasingly important amid great-power rivalry. Lux's internal process depends on partners challenging one another, identifying disconfirming evidence, and avoiding the trap of becoming euphoric during boom periods.

Data Points: Lux Capital assets under management: $4 billion - Josh Wolfe describes Lux Capital's size while discussing its investing approach. Current opportunity fund deployment target: $20-25 million this year - Wolfe says Lux is intentionally seeding Africa-related opportunities with the expectation that some will fail. Control Labs founder proceeds in Facebook sale: ~$95-100 million personal payout - Wolfe recounts realizing the transaction was life-changing for a founder living in a dorm room. Facebook offer escalation: Nearly tripled - He says Facebook's later offer made the sale much more attractive financially. Variant Bio partnerships: 14 partnerships in ~1.5 years - The company built a global sourcing network for genetic targets during COVID. Variant Bio financing: $105 million - Wolfe mentions a financing led by SoftBank and other investors. Public venture drawdown reference: 78% decline - He compares a potential future correction to the dot-com bust, when the NASDAQ fell sharply. Dot-com recovery time: 12 years to recover nominally; ~17 years with inflation - Used to illustrate the severity and duration of a bubble unwind. Current crypto market cap range cited: $2.5-3 trillion - Wolfe discusses Bitcoin and Ethereum dominance in today's crypto market. Potential gold-market analog for crypto: $5.5 trillion - He uses half of the $11 trillion gold market as a possible long-term store-of-value comparison. Nuclear power share of U.S. electricity: Nearly 20% - He cites existing nuclear infrastructure to argue for rebranding as 'elemental power.' U.S. domestic nuclear plants: 104 plants - Provided to show nuclear already exists at scale in the United States. DOE waste cleanup budget cited: $6 billion of $25 billion - Wolfe uses this to show a large underappreciated market in nuclear waste remediation.

Pivotal Quotes: "There is, as I've described it now, an excess of excesses." — Josh Wolfe: His summary of the venture capital environment today. "Failure comes from a failure to imagine failure." — Josh Wolfe: Explaining Lux's risk-first decision framework. "I tried moral suasion, financial suasion. I tried everything." — Josh Wolfe: Reflecting on his attempt to prevent Control Labs from selling to Facebook.

Implications: Listeners should expect a tougher venture environment ahead, with selection increasingly favoring patient, technical, differentiated investors. The next major returns may come from science, defense, space, and overlooked regions like Africa rather than crowded software auctions.

🔓 Sign Up for Unlimited Episode Search

About Capital Allocators

Allocator and asset management expert, Ted Seides, conducts in-depth interviews with leaders in the institutional investing industry. Guests include Chief Investment Officers from leading allocators, asset managers, strategists, thought leaders, and many more. Our mission is to learn, share, and help implement the process of premier investors. Learn more and join our community at capitalallocators.com.

View all episodes from Capital Allocators